Answers are grounded in this paper and cite their sources.
Limited evidence suggests that broad-spectrum fluoroquinolones such as gatifloxacin and moxifloxacin are more likely to cause Clostridium difficile-associated disease than levofloxacin. In a population-based case-control study of outpatients prescribed fluoroquinolones, we found no increased risk of C. difficile-associated disease requiring hospitalization among patients prescribed gatifloxacin or moxifloxacin compared to levofloxacin.
No takes yet. Share an insight, caveat, or question.
Dhalla et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: